Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome

Rheumatology International

Volumn 31, Issue 8, 2011, Pages 1045-1049

  Yavuz, Sule ^a   Asfuroğlu, Esra ^a   Bicakcigil, Muge ^b   Toker, Ebru ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

BAFF; Hydroxychloroquine; Sjogren's syndrome; Xerophthalmia

Indexed keywords

ARTIFICIAL TEAR; B CELL ACTIVATING FACTOR; DYE; FLUORESCEIN; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORNEA; DIAGNOSTIC TEST; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DRY EYE; EYE; FEMALE; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; HUMAN; LACRIMAL FLUID; LOW DRUG DOSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCHIRMER TEST; SCORING SYSTEM; SJOEGREN SYNDROME; STAINING; SYMPTOM; TEAR BREAK UP TIME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; XEROPHTHALMIA;

EID: 79961172421     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1415-4     Document Type: Article

References (24)

1. Manoussakis MN, Moutsopoulos HM (2006) Sjögren's syndrome. In: Rose NR, Mackay IR (eds) The autoimmune diseases, 4th edn. Elsevier, St Louis, pp 401-416
2. PJ Venables 2006 Management of patients presenting with Sjogren's syndrome Best Pract Res Clin Rheumatol 20 4 791 807 16979538 10.1016/j.berh.2006.05.003 1:STN:280:DC%2BD28rltlSitg%3D%3D (Pubitemid 44350119)
3. F Mackay JR Groom SG Tangye 2007 An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome Curr Opin Rheumatol 19 5 406 413 17762603 10.1097/BOR.0b013e328277ef4c 1:CAS:528:DC%2BD2sXpvVensb0%3D (Pubitemid 47344230)
4. J Groom SL Kalled AH Cutler, et al. 2002 Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome J Clin Invest 109 59 68 11781351 1:CAS:528:DC%2BD38XjtlaktQ%3D%3D (Pubitemid 34052542)
5. JO Pers C Daridon V Devauchelle, et al. 2005 BAFF overexpression is associated with autoantibody production in autoimmune diseases Ann N Y Acad Sci 1050 34 39 16014518 10.1196/annals.1313.004 1:CAS:528:DC%2BD2MXhtVWgtrzN (Pubitemid 41129420)
6. C Daridon V Devauchelle P Hutin, et al. 2007 Abberant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome Arthritis Rheum 56 1134 1144 17393395 10.1002/art.22458 1:CAS:528:DC%2BD2sXltFKgsrg%3D (Pubitemid 46608638)
7. X Mariette S Roux J Zhang, et al. 2003 The level of BLys (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome Ann Rheum Dis 62 168 171 12525388 10.1136/ard.62.2.168 1:STN:280: DC%2BD3s%2FktlCqtA%3D%3D (Pubitemid 36135394)
8. RI Fox R Dixon V Guarrasi S Krubel 1996 Treatment of primary Sjogren's syndrome with hydroxychloroquine; a retrospective, open-label study Lupus 5 31 36 10.1177/096120339600500108
9. AA Kruize RJ Hene CG Kallenberg, et al. 1993 Hydroxychloroquine treatment for primary Sjogren's syndrome; a two year, double blind cross over trial Ann Rheum Dis 52 60 64 10.1136/ard.52.5.360
10. C Vitali S Bombardieri HM Moutsopoulos 2002 Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group Ann Rheum Dis 61 554 558 12006334 10.1136/ard.61.6.554 1:STN:280:DC%2BD383pvFyhtA%3D%3D (Pubitemid 34539104)
11. AJ Bron VE Evans JA Smith 2003 Grading of corneal and conjunctival staining in the context of other dry eye tests Cornea 22 640 650 14508260 10.1097/00003226-200310000-00008 (Pubitemid 37175145)
12. M Rihl K Ulbricht RE Schmidt T Witte 2009 Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome Rheumatology 48 7 796 799 19433433 10.1093/rheumatology/kep104 1:CAS:528:DC%2BD1MXnslKhu7o%3D
13. LJ Dawson VL Caulfield JB Stanbury, et al. 2005 Hydroxychloroquine therapy in patients with primary Sjogren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase Rheumatology 44 449 455 15590764 10.1093/rheumatology/keh506 1:CAS:528:DC%2BD2MXisVGqtr8%3D (Pubitemid 41511132)
14. E Toker E Asfuroglu 2010 Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy Cornea 29 2 133 140 19966564 10.1097/ICO.0b013e3181acf68d
15. F Brignole PJ Pisella M Goldschild, et al. 2000 Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes Invest Ophthalmol Vis Sci 41 1356 1363 10798650 1:STN:280: DC%2BD3c3ls1Gjug%3D%3D (Pubitemid 30261857)
16. ME Stern J Gao TA Schwalb, et al. 2002 Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye Invest Ophthalmol Vis Sci 43 2609 2614 12147592 (Pubitemid 34809449)
17. SC Pflugfelder D Jones Z Ji, et al. 1999 Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca Curr Eye Res 19 201 211 10487957 10.1076/ceyr.19.3. 201.5309 1:STN:280:DyaK1MvhvV2lsw%3D%3D (Pubitemid 29500267)
18. A Solomon D Dursun Z Liu, et al. 2001 Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry eye disease Invest Ophthalmol Vis Sci 42 2283 2292 11527941 1:STN:280: DC%2BD3MvosFyjtg%3D%3D (Pubitemid 32848857)
19. VA Smith H Rishmawi H Hussein, et al. 2001 Tear film MMP accumulation and corneal disease Br J Ophthalmol 85 147 153 11159476 10.1136/bjo.85.2.147 1:STN:280:DC%2BD3M7kvFSjsw%3D%3D (Pubitemid 32146751)
20. M Thien TG Phan S Gardam, et al. 2004 Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches Immunity 20 785 798 15189742 10.1016/j.immuni.2004.05. 010 1:CAS:528:DC%2BD2cXltlKisbo%3D (Pubitemid 38757447)
21. M Ittah C Micelli-Richard JE Gottenberg, et al. 2006 B cell activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cell in primary Sjogren's syndrome Arthritis Res Ther 8 R51 16507175 10.1186/ar1912
22. S Candon JE Gottenberg D Bengoufa L Chatenoud X Mariette 2009 Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren's syndrome: correlation with B cell biomarkers and disease activity Ann Rheum Dis 68 7 1208 1212 18713786 10.1136/ard.2008.095257 1:CAS:528:DC%2BD1MXovVCms7w%3D
23. E Toker S Yavuz H Direskeneli 2004 Anti-Ro/SSAA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome Br J Ophthalmol 88 384 387 14977774 10.1136/bjo.2003.028340 1:STN:280: DC%2BD2c%2FovValsA%3D%3D (Pubitemid 38333719)
24. S Yavuz E Toker M Bicakcigil G Mumcu S Cakir 2006 Comparative analysis of autoantibodies against αfodrin in serum, tear fluid, and saliva from patients with Sjögren's Syndrome J Rheumatol 33 1289 1292 16821267 1:CAS:528:DC%2BD28XnslWjt78%3D (Pubitemid 44025142)